Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines

US8436003B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Stephan Siegel · Berlin, DE
• Andreas Wilmen
• Niels Svenstrup · Copenhagen, DK
• Mark Jean Gnoth · Mettmann, DE
• Adrian Tersteegen · Wuppertal, DE
• Ulrich Rester · Wuppertal, DE

Key dates

• Filing date: May 2, 2009
• Grant date: May 7, 2013
• Expiry date: May 24, 2029

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P7/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to substituted triazolopyrimidines of the formulaprocesses for their preparation, and their use for the treatment of hematological disorders.